Calciphylaxis is seen in CKD patients due to?
**Core Concept**
Calciphylaxis, also known as calcific uremic arteriolopathy, is a serious and potentially life-threatening complication of chronic kidney disease (CKD). It involves the deposition of calcium and phosphate in the small arteries and arterioles, leading to vascular calcification and thrombosis.
**Why the Correct Answer is Right**
The pathogenesis of calciphylaxis is multifactorial, but it primarily involves the imbalance of calcium and phosphate metabolism in CKD patients. The increased levels of parathyroid hormone (PTH) and phosphate, along with decreased levels of calcitriol (1,25-dihydroxyvitamin D), contribute to the deposition of calcium and phosphate in the vascular walls. This process leads to vascular calcification, inflammation, and ultimately, thrombosis and tissue necrosis.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because while hyperphosphatemia is a contributing factor to calciphylaxis, it is not the primary cause.
**Option B:** This option is incorrect because while PTH levels are elevated in CKD patients, the direct cause of calciphylaxis is the deposition of calcium and phosphate in the vascular walls, not the elevated PTH levels alone.
**Option C:** This option is incorrect because while calcitriol deficiency is a contributing factor to calciphylaxis, it is not the primary cause.
**Clinical Pearl / High-Yield Fact**
Calciphylaxis is often associated with a poor prognosis, with mortality rates ranging from 30% to 70%. Early recognition and treatment are crucial to prevent further complications.
**Correct Answer: D. The imbalance of calcium and phosphate metabolism in CKD patients, leading to vascular calcification and thrombosis.**